Leuvas Therapeutics, Inc management

The Founding Team

Eugene Butcher, M.D., Director and Co-Founder, Chair of SAB

  • Klaus Bensch Professor in Pathology, Stanford School of Medicine
  • Internationally recognized leader in leukocyte trafficking, leukocyte-vascular interactions, vascular biology, and systems biology
  • Co-founder/key advisor to multiple biotechnology companies, eg, BioSeek, LeukoSite, Millenium

Gabriela Constantin, M.D., Ph.D., Director and Co-Founder

  • Professor of Pathology and Immunology, University of Verona
  • Recognized leader in neuroimmunology, neuroinflammatory disease, multiple sclerosis, Alzheimer's disease, and leukocyte trafficking; frequent industry collaborator/advisor
  • Innovative laboratory with game-changing approaches to LVI studies and neurobiology

Paolo Fabene, Ph.D., Co-Founder

  • Professor of Anatomy, University of Verona
  • World-class neurology/behavior laboratory; video-telemetric EEG analysis
  • Recognized leader in LVI-epilepsy, epileptogenesis and neuroinflammatory models

Carlo Laudanna, M.D., Ph.D., Co-Founder

  • Professor of Anatomy, University of Verona
  • Recognized leader in molecular mechanisms controlling leukocyte trafficking, signaling

Leslie McEvoy, Ph.D., CEO, Director and Co-Founder

  • Experienced biotechnology executive in pre-clinical, clinical and commercial-stage public and private companies.
  • Former EVP, head of research and development, Corgentech, Anesiva Inc.